BTK and mantle cell lymphoma: Prolonged exposure to kinase inhibitors such as BTK inhibitors as seen in the MCL case morphed into sarcoma (29), could certainly be a factor promoting BCR/BTK independence including transdifferentiation and a related profound cell-signaling reprograming, as a very drastic mechanism of drug resistance.